Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
Unlock the market timeline & signal feed
769 signals in the last 90 days.
The order this company entered each market — oldest to newest
29 active postings
41 active postings
Sign up to see the full signal feed
How Roche's international expansion compares to its competitors
RocheYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 RocheYou | 65 | 0 | +1% | 725 | 39 |
Internship in Molecular Biology/Biotechnology R&D (m/f/d)
View postingPenzberg, Bavaria, Germany · yesterday
Group Leader Medical Affairs (Multiple Sclerosis)
View postingWelwyn, England, United Kingdom · yesterday
Employee Lifecycle Management Specialist
View postingMadrid, Community of Madrid, Spain · yesterday
Impulsar el diagnóstico temprano es clave en una región donde muchos casos aún se identifican en etapas avanzadas. Fortalecer la sospecha clínica y la derivación oportuna puede marcar una diferencia real.¿Qué barreras ves hoy en tu práctica diaria?💡Fuente: https://spkl.io/604276b4k ...
Active
A new era in sequencing
EndedA new era in sequencing
EndedRoche Korea announces insurance coverage for Vabysmo prefilled syringe from April 1st, improving treatment accessibility for retinal diseases.
Innovent Biologics presented preclinical data for IBI3055, a novel anti-CD19/BCMA/CD3 trispecific antibody, at the Immune Resetting Summit, demonstrating effective B-cell and plasma cell depletion for autoimmune diseases.
KMDIA International Exchange Committee launches Medi-Talk webinars and open innovation platform to support Korean medical device companies' US market entry and startup development through networking with multinational firms.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Roche's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
